This study focuses on adults experiencing episodic migraine attacks and evaluates a potential new acute treatment option. The investigational medication is taken at the onset of a moderate to severe migraine episode.
Researchers aim to understand how quickly it can reduce headache pain and associated symptoms such as nausea and sensitivity to light and sound.
It is designed to be used during attacks rather than as a daily preventive therapy.
This trial will assess the safety, tolerability, and effectiveness of the investigational oral medication. Researchers will measure symptom relief, including pain reduction, within approximately two hours after dosing.
Participants will receive study-related care and monitoring at no cost throughout the study duration.
The findings may support the development of faster-acting migraine treatment options for adults.
